Skip to main content

Table 2 Odds of having metabolic syndrome according to presence of depressive symptoms and use of antidepressant medications in the Maine-Syracuse Longitudinal Study

From: Association between depressive symptoms, use of antidepressant medication and the metabolic syndrome: the Maine-Syracuse Study

Depressive symptoms/medication use Covariate seta Quartile of scoresb MetS
OR 95 % CI P-value
CES-D score Basic Q4 1.79 1.22, 2.62 0.003
   Q3 1.35 0.93, 1.97 0.1
   Q2 1.05 0.72, 1.54 0.8
   Q1 1.00   
  Extended Q4 1.50 1.00, 2.24 0.049
   Q3 1.23 0.83, 1.82 0.3
   Q2 0.99 0.66, 1.49 0.9
   Q1 1.00   
Zung score Basic Q4 1.71 1.17, 2.50 0.006
   Q3 1.20 0.81, 1.77 0.4
   Q2 1.14 0.79, 1.65 0.5
   Q1 1.00   
  Extended Q4 1.43 0.99, 2.50 0.1
   Q3 0.99 0.66, 1.52 0.9
   Q2 1.05 0.71, 1.54 0.8
   Q1 1.00   
Antidepressant medication use Basic Yes 2.31 1.51, 3.54 <0.001
  No 1.00   
  Extended Yes 2.22 1.42, 3.48 <0.001
   No 1.00   
  1. CES-D Center for Epidemiologic Studies Depression Scale, CI confidence interval, MetS metabolic syndrome, OR odds ratio
  2. aBasic: adjusted for age, education, sex, ethnicity; Extended: adjusted for set 1 + smoking (cigarettes per day), physical activity (MET-minutes/day), CRP (mg/L)
  3. bQuartile 1 (lowest quartile of scores) = reference group